New developments and new dilemmas in lower-grade gliomas

Affiliations

Comment

Roberta Rudà. Neuro Oncol. 2019.

. 2019 Jul 11;21(7):828-829.

doi: 10.1093/neuonc/noz062.

No abstract available

Comment on

Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus.
Schiff D, Van den Bent M, Vogelbaum MA, Wick W, Miller CR, Taphoorn M, Pope W, Brown PD, Platten M, Jalali R, Armstrong T, Wen PY. Schiff D, et al. Neuro Oncol. 2019 Jul 11;21(7):837-853. doi: 10.1093/neuonc/noz033. Neuro Oncol. 2019. PMID: 30753579 Free PMC article. Review.

1. Schiff D, van den Bent M, Vogelbaum MA, et al. . Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association for Neuro-Oncology (EANO) perspective. Neuro Oncol. 2019. (in press). doi: 10.1093/neuonc/noz033 - DOI - PMC - PubMed
1. Louis DN, Perry A, Reifenberger G, et al. . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
1. Brat DJ, Aldape K, Colman H, et al. . cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”. Acta Neuropathol. 2018;136(5):805–810. - PMC - PubMed
1. Aibaidula A, Chan AK, Shi Z, et al. . Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro Oncol. 2017;19(10):1327–1337. - PMC - PubMed
1. Capper D, Jones DTW, Sill M, et al. . DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469–474. - PMC - PubMed